Key result
Newer type 2 diabetes therapies substantially reduce cardiorenal risk, supporting updated primary care paradigms.
Answers are grounded in this paper and cite their sources.
Type 2 diabetes is a prevalent illness that causes major vascular, renal, and neurologic complications. Prevention and treatment of diabetes and its complications are of paramount importance. Many new treatments have emerged over the past 5-10 years. Recent evidence shows that newer treatments may substantially reduce risk for cardiac and renal disease, suggesting that it may be necessary to change existing treatment paradigms. This review summarizes the evidence supporting diabetes prevention and treatment, focusing on aspects that are commonly in the purview of primary care physicians.
No takes yet. Share an insight, caveat, or question.
Sandeep Vijan (2019) conducted a review in Type 2 diabetes. Newer treatments for Type 2 diabetes was evaluated. Newer treatments for Type 2 diabetes may substantially reduce the risk for cardiac and renal disease, suggesting a need to update existing treatment paradigms in primary care.
Synapse has enriched 10 related papers. Consider them for comparative context: